Acquisition of Feinstein Kean Partners

WPP Group PLC
8 November 1999


                              WPP GROUP PLC ('WPP')

Acquisition of Feinstein Kean Partners, Inc, a leading US healthcare and
biotechnology public relations firm

WPP has agreed to acquire, on behalf of. its wholly-owned
subsidiary Ogilvy Public Relations Worldwide, Feinstein Kean
Partners, Inc, ('Feinstein') a leading US-based healthcare
and biotechnology public relations firm. The acquisition
makes Ogilvy PR the world's second largest full service PR
firm in healthcare communications.

Cambridge Massachusetts-based Feinstein has a reputation for its special
expertise in marketing communications for the pharmaceutical and biotechnology
industries.

Feinstein will operate alongside Ogilvy PR's established $23million healthcare
practice, under its new name of Feinstein Kean Healthcare ('FKH') working to
promote the coming generation of biotechnology-based pharmaceuticals.

FKH's services include corporate communications, investor relations, product
promotion, communications with patients and healthcare professionals,
graphics and Internet communications and, through its subsidiary Kendall
Strategies, strategic consulting in the areas of business development and
marketing.

FKH and Kendall Strategies have more than 70 employees with expected 1999
revenues of more than $9million. Feinstein had net assets of $1.9 million at
30 June 1999.

The combined resource of Feinstein and Ogilvy PR will enable the enlarged firm
to deliver superior communications services to both the emerging biotechnology
clients and to the major pharmaceutical companies.

Feona McEwan at WPP London                00 44 171 408 2204

www.wpp.com 
www.ogilvypr.com